Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Elixir Department: SOP for Recording Parameters in BMR – V 2.0

Posted on By

Elixir Department: SOP for Recording Parameters in BMR – V 2.0

Standard Operating Procedure for Recording Parameters in Batch Manufacturing Record (BMR)

Department Elixir Department
SOP No. SOP/ELX/069/2025
Supersedes SOP/ELX/069/2022
Page No. Page 1 of 8
Issue Date 11/04/2025
Effective Date 15/04/2025
Review Date 11/04/2026

1. Purpose

To define the procedure for accurately recording all process parameters, observations, and verification steps in the Batch Manufacturing Record (BMR) during the manufacturing of elixirs.

2. Scope

This SOP applies to all manufacturing stages of elixirs in the Elixir Department, including dispensing, mixing, heating/cooling, filtration, and filling, where critical data must be documented in the BMR.

3. Responsibilities

  • Production Operator:
    • Record parameters such as temperature, speed, time, and volume in the respective BMR fields.
    • Sign and date each entry immediately after recording.
  • Production Supervisor:
    • Verify entries for correctness, completeness, and legibility.
    • Ensure any corrections follow GMP-compliant documentation practices.
  • QA Officer:
    • Review completed BMRs before batch release.
    • Ensure no critical parameters are missed or falsified.
See also  Elixir Department: SOP for Limit Test for Chloride and Sulfates - V 2.0

4. Accountability

The Production Head is accountable for maintaining the accuracy, integrity, and compliance of all recorded parameters in the BMR.

5. Procedure

5.1 General Instructions

  1. Use only indelible black or blue ink for all handwritten entries.
  2. Do not use correction fluid or overwrite any entry.
  3. If an error occurs, strike a single line through the incorrect entry, write the correct value, and sign with date and reason.

5.2 Recording Process Parameters

  1. Record the following parameters in the BMR:
    • Dispensed quantities and batch numbers of raw materials.
    • Mixing speed (RPM), temperature, and duration.
    • Heating and cooling cycles with start and stop times.
    • pH readings and adjustments, if applicable.
    • Volume adjustments and final volume check.
    • Filtration start and end times, filter type used.
    • Sampling time points and personnel initials.
See also  Elixir Department: SOP for Compressed Air System in Mixing Units - V 2.0

5.3 In-Process Observations

  1. Note any unusual observations (e.g., foaming, odor, color change) along with action taken.
  2. Record deviations with reference to the deviation report number, if applicable.

5.4 Verification and Review

  1. Supervisor must verify entries within the same shift and sign with date.
  2. QA review should be done after process completion and documented in the QA review section of the BMR.

5.5 Archival

  1. After final QA release, BMRs must be archived in the QA documentation room as per document retention policy.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • BMR: Batch Manufacturing Record
  • QA: Quality Assurance
  • GMP: Good Manufacturing Practice

7. Documents

  1. BMR Template (Annexure-1)
  2. Correction Log Sheet (Annexure-2)
  3. QA Review Form (Annexure-3)

See also  Elixir Department: SOP for Addition of Volatile and Flavoring Agents - V 2.0

8. References

  • 21 CFR Part 211.188 – Batch Production and Control Records
  • WHO TRS 986 Annex 2 – GMP Documentation Guidelines

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: BMR Template

Section Parameter Recorded Value Date/Time Initials
Mixing RPM 60 11/04/2025 – 10:30 AM RK

Annexure-2: Correction Log Sheet

Date Original Entry Corrected Entry Reason Corrected By
11/04/2025 85°C 58°C Typo Rajesh Kumar

Annexure-3: QA Review Form

Date Batch No. Reviewed By Remarks Status
11/04/2025 ELX-1013 Sunita Reddy Complete and correct Approved

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial Release New SOP QA Head
11/04/2025 2.0 Added Correction Log and QA Review Form GMP Documentation Update QA Head
Elixers V 2.0 Tags:Elixir colorants, Elixir dosage form, Elixir filtration techniques, Elixir flavoring agents, Elixir formulation, Elixir GMP compliance, Elixir manufacturing process, Elixir manufacturing SOPs, Elixir packaging requirements, Elixir pharmacopoeial standards, Elixir preparation methods, Elixir preservatives, Elixir production equipment, Elixir quality control, Elixir regulatory guidelines, Elixir shelf life, Elixir stability testing, Elixir sterilization methods, Elixir storage conditions, Elixir sweetening agents, Elixir viscosity modifiers, Hydroalcoholic solutions, Medicated elixirs, Non-medicated elixirs, Pharmaceutical elixirs

Post navigation

Previous Post: Analytical Method Development: Related Substances Method Development by HPLC – V 2.0
Next Post: Creams: SOP for Verification of Test Results in QC Laboratories – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version